Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A10559 | Pages: 186 | Charts: 38 | Tables: 92 |
The global medical thawing system market was valued at $165.82 million in 2019, and is expected to reach $279.17 million by 2027 with a CAGR of 11.6% during the forecast period.
Medical thawing is an essential step used during a blood transfusion. As blood and plasma-based products are stored in cold conditions, thawing them is essential to ensure safe transfusion. Thawing system uses microprocessors to regulate water bath temperature for appropriate thawing. It is performed for cryopreserved ovum, semen, and embryo samples. In addition, increase in use of fresh frozen plasma and blood products increases demand of medical thawing systems.
Get more information on this report : Request Sample Pages
Rise in incidences of chronic disease leading to demand for blood and plasma products, rise in launches & agreements, and technological advancements to ease and simplify the process of thawing are the major factors that propel the market growth. In addition, rise in awareness and government initiatives toward plasma donation, increase in number of embryo donors, and rise in awareness regarding third-party reproduction further propels growth of the medical thawing system market. However, high cost of automation of thawing machines hinders the market growth. Moreover, the dire need for novel medicinal inventions is expected to propel adoption of thawing systems, which is expected to provide lucrative opportunities for the market growth during the forecast period.
The coronavirus disease (COVID-19) has spread across the globe. Hence, owing to increase in number of corona virus patients, governments have imposed several rules and lockdowns across the globe, which has resulted into postponing of non-emergency surgical procedures as well as in-hospital therapies. Healthcare providers are concentrating more on offering emergency healthcare to patients infected with coronavirus. Further, the Defense Department in the U.S. has started an effort to collect 8,000 donated units of plasma from patients who have recovered from COVID-19 to support development of an effective treatment against the disease. In addition, thawing is an important part in drug discovery and research & development during COVID-19 drugs/vaccine preparations. Therefore, the aforementioned factors are expected to show moderate effect on the market growth during the forecast period.
The medical thawing system market is divided on the basis of sample type, end user, and region. By sample, the market is segmented into blood, embryo, ovum, and semen. On the basis of end user, it is segmented into blood banks, hospitals, tissue banks, pharmaceutical and biotech companies, and others. On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By sample type, the global medical thawing system market is categorized into blood, embryo, ovum, and semen. The blood segment is expected to dominate the market during the forecast period. This is attributed to rise in demand for blood & blood products and increase in incidences of hemorrhage related events. Further, the embryo segment is estimated to grow rapidly during the forecast period, owing to increase in rate of pregnancy and live birth by embryo donation. Furthermore, increase in adoption of in vitro fertilization (IVF) treatment for infertility also propel the demand for advanced thawing systems.
[SAMPLETYPEGRAPH]
Get more information on this report : Request Sample Pages
On the basis of end user, the market is segregated into blood banks, hospitals, tissue banks, pharmaceutical & biotech companies, and others. The blood bank segment dominated the market in 2019, owing to vast utilization of thawing systems in transfusion centers and blood banks. Further, the tissue bank segment is estimated to grow at the fastest rate during the forecast period, as these institutions recover and store human cadaver tissues for medical studies and education. Mostly tissues such as cartilage, skin, tendons, bone joints, cornea, and dura mater are harvested and stored by these institutions.
[ENDUSERGRAPH]
Get more information on this report : Request Sample Pages
Region wise, the global medical thawing system market is analyzed across North America, Region wise, the global medical thawing system market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America dominated the market in 2019, owing to increase in awareness programs regarding blood donation and plasma donation. In addition, presence of leading market players such as Boekel Scientific, GE healthcare, and Helmer Scientific further propels growth of medical thawing system market in this region. However, Asia-Pacific is expected to register highest CAGR, in terms of revenue, during the forecast period, as the region has a large patient pool with high incidences of chronic diseases. Increase in the number of chronic diseases that lead to organ failures is expected to boost demand for thawed blood.
[REGIONGRAPH]
Get more information on this report : Request Sample Pages
Prominent players operating in the global medical thawing system market include Barkey GmbH & Co. KG, Boekel Scientific, BioLife Solutions Inc, Cardinal Health, Inc., General Electric Company, Helmer Scientific, Sartorius AG, Sarstedt AG & Co. KG, Terumo Corporation, and Thermo Fisher Scientific Inc. These players are adopting growth strategies such as product launches, mergers and acquisitions (M&As), product developments, and partnerships & collaborations to gain competitive advantage.
Key Benefits For Stakeholders
Key Market Segments
Key Market Players
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning, 2019
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Increase in incidences of chronic disease leading to demand for blood and plasma products
3.5.1.2.Technological advancement to ease and simply the process of thawing
3.5.1.3.Rise in awareness and government initiative towards the plasma donation
3.5.1.1.Rise in launches and agreement of medical thawing systems
3.5.1.2.Increase in number of embryo donors and rise in awareness of third party reproduction
3.5.2.Restraints
3.5.2.1.High cost of the automation
3.5.3.Opportunities
3.5.3.1.Dire need for novel medicinal inventions to push adoption of thawing systems
3.5.4.Impact analysis
3.6.Impact analysis of COVID-19 on medical thawing system market
CHAPTER 4:MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Blood
4.2.1.Key developments and tends
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Embryo
4.3.1.Key developments and tends
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Ovum
4.4.1.Key market trends and opportunity
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
4.5.Semen
4.5.1.Key market trends and opportunity
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country
CHAPTER 5:MEDICAL THAWING SYSTEM MARKET, BY END USER
5.1.Overview
5.1.1.Market size and forecast, by end user
5.2.Blood Banks
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Hospitals
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Tissue Banks
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
5.5.Pharmaceutical and Biotech Companies
5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country
5.6.Others
5.6.1.Market size and forecast, by region
5.6.2.Market analysis, by country
CHAPTER 6:MEDICAL THAWING SYSTEM MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.Key market trends and opportunities
6.2.2.North America market size and forecast, by sample type
6.2.3.North America market size and forecast, by end user
6.2.4.North America market size and forecast, by country
6.2.5.U.S.
6.2.5.1.U.S. market size and forecast, by sample type
6.2.5.2.U.S. market size and forecast, by end user
6.2.6.Canada
6.2.6.1.Canada market size and forecast, by sample type
6.2.6.2.Canada market size and forecast, by end user
6.2.7.Mexico
6.2.7.1.Mexico market size and forecast, by sample type
6.2.7.2.Mexico market size and forecast, by end user
6.3.Europe
6.3.1.Key market trends and opportunities
6.3.2.Europe market size and forecast, by sample type
6.3.3.Europe market size and forecast, by end user
6.3.4.Europe market size and forecast, by country
6.3.5.Germany
6.3.5.1.Germany market size and forecast, by sample type
6.3.5.2.Germany market size and forecast, by end user
6.3.6.France
6.3.6.1.France market size and forecast, by sample type
6.3.6.2.France market size and forecast, by end user
6.3.7.UK
6.3.7.1.UK market size and forecast, by sample type
6.3.7.2.UK market size and forecast, by end user
6.3.8.Italy
6.3.8.1.Italy market size and forecast, by sample type
6.3.8.2.Italy market size and forecast, by end user
6.3.9.Spain
6.3.9.1.Spain market size and forecast, by sample type
6.3.9.2.Spain market size and forecast, by end user
6.3.10.Rest of Europe
6.3.10.1.Rest of Europe market size and forecast, by sample type
6.3.10.2.Rest of Europe market size and forecast, by end user
6.4.Asia-Pacific
6.4.1.Key market trends and opportunities
6.4.2.Asia-Pacific market size and forecast, by sample type
6.4.3.Asia-Pacific market size and forecast, by end user
6.4.4.Asia-Pacific market size and forecast, by country
6.4.5.Japan
6.4.5.1.Japan market size and forecast, by sample type
6.4.5.2.Japan market size and forecast, by end user
6.4.6.China
6.4.6.1.China market size and forecast, by sample type
6.4.6.2.China market size and forecast, by end user
6.4.7.Australia
6.4.7.1.Australia market size and forecast, by sample type
6.4.7.2.Australia market size and forecast, by end user
6.4.8.India
6.4.8.1.India market size and forecast, by sample type
6.4.8.2.India market size and forecast, by end user
6.4.9.South Korea
6.4.9.1.South Korea market size and forecast, by sample type
6.4.9.2.South Korea market size and forecast, by end user
6.4.10.Rest of Asia-Pacific
6.4.10.1.Rest of Asia-Pacific market size and forecast, by sample type
6.4.10.2.Rest of Asia-Pacific market size and forecast, by end user
6.5.LAMEA
6.5.1.Key market trends and opportunities
6.5.2.LAMEA market size and forecast, by sample type
6.5.3.LAMEA market size and forecast, by end user
6.5.4.LAMEA market size and forecast, by country
6.5.5.Brazil
6.5.5.1.Brazil market size and forecast, by sample type
6.5.5.2.Brazil market size and forecast, by end user
6.5.6.Saudi Arabia
6.5.6.1.Saudi Arabia market size and forecast, by sample type
6.5.6.2.Saudi Arabia market size and forecast, by end user
6.5.7.South Africa
6.5.7.1.South Africa market size and forecast, by sample type
6.5.7.2.South Africa market size and forecast, by end user
6.5.8.Rest of LAMEA
6.5.8.1.Rest of LAMEA market size and forecast, by sample type
6.5.8.2.Rest of LAMEA market size and forecast, by end user
CHAPTER 7:COMPANY PROFILES
7.1.BARKEY GMBH & CO. KG
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.2.BOEKEL SCIENTIFIC
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.3.BIOLIFE SOLUTIONS INC.
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.4.CARDINAL HEALTH INC.
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.5.GENERAL ELECTRIC COMPANY (GE HEALTHCARE)
7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.6.HELMER SCIENTIFIC
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
7.7.SARTORIUS AG
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Business performance
7.8.SARSTEDT AG & CO. KG
7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.9.TERUMO CORPORATION
7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance
7.10.THERMO FISHER SCIENTIFIC, INC.
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance
LIST OF TABLES
TABLE 01.GLOBAL MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019–2027 ($MILLION)
TABLE 02.BLODD MEDICAL THAWING SYSTEM MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 03.EMBRYO MEDICAL THAWING SYSTEM, BY REGION, 2019–2027 ($MILLION)
TABLE 04.OVUM MEDICAL THAWING SYSTEM, BY REGION, 2019–2027 ($MILLION)
TABLE 05.SEMEN MEDICAL THAWING SYSTEM, BY REGION, 2019–2027 ($MILLION)
TABLE 06.GLOBAL MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 07.BLOOD BANK MEDICAL THAWING SYSTEM MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 08.HOSPITAL MEDICAL THAWING SYSTEM, BY REGION, 2019-2027 ($MILLION)
TABLE 09.TISSUE BANK MEDICAL THAWING SYSTEM, BY REGION, 2019-2027 ($MILLION)
TABLE 10.PHARMACEUTICAL AND BIOTECH COMPANIES MEDICAL THAWING SYSTEM, BY REGION, 2019-2027 ($MILLION)
TABLE 11.OTHERS MEDICAL THAWING SYSTEM, BY REGION, 2019-2027 ($MILLION)
TABLE 12.MEDICAL THAWING SYSTEM MARKET, BY REGION, 2019–2027, ($MILLION)
TABLE 13.NORTH AMERICA MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019–2027, ($MILLION)
TABLE 14.NORTH AMERICA MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 15.NORTH AMERICA MEDICAL THAWING SYSTEM MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 16.U.S. MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019–2027, ($MILLION)
TABLE 17.U.S. MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 18.CANADA MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019–2027, ($MILLION)
TABLE 19.CANADA MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 20.MEXICO MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019–2027, ($MILLION)
TABLE 21.MEXICO MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 22.EUROPE MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019–2027, ($MILLION)
TABLE 23.EUROPE MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 24.EUROPE MEDICAL THAWING SYSTEM MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 25.GERMANY MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019–2027, ($MILLION)
TABLE 26.GERMANY MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 27.FRANCE MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019–2027, ($MILLION)
TABLE 28.FRANCE MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 29.UK MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019–2027, ($MILLION)
TABLE 30.UK MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 31.ITALY MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019–2027, ($MILLION)
TABLE 32.ITALY MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 33.SPAIN MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019–2027, ($MILLION)
TABLE 34.SPAIN MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 35.REST OF EUROPE MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019–2027, ($MILLION)
TABLE 36.REST OF EUROPE MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 37.ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019–2027, ($MILLION)
TABLE 38.ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 39.ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 40.JAPAN MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019–2027, ($MILLION)
TABLE 41.JAPAN MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 42.CHINA MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019–2027, ($MILLION)
TABLE 43.CHINA MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 44.AUSTRALIA MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019–2027, ($MILLION)
TABLE 45.AUSTRALIA MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 46.INDIA MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019–2027, ($MILLION)
TABLE 47.INDIA MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 48.SOUTH KOREA MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019–2027, ($MILLION)
TABLE 49.SOUTH KOREA MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 50.REST OF ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019–2027, ($MILLION)
TABLE 51.REST OF ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 52.LAMEA MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019–2027, ($MILLION)
TABLE 53.LAMEA MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 54.LAMEA MEDICAL THAWING SYSTEM MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 55.BRAZIL MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019–2027, ($MILLION)
TABLE 56.BRAZIL MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 57.SAUDI ARABIA MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019–2027, ($MILLION)
TABLE 58.SAUDI ARABIA MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 59.SOUTH AFRICA MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019–2027, ($MILLION)
TABLE 60.SOUTH AFRICA MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 61.REST OF LAMEA MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019–2027, ($MILLION)
TABLE 62.REST OF LAMEA MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 63.BARKEY: COMPANY SNAPSHOT
TABLE 64.BARKEY: OPERATING SEGMENTS
TABLE 65.BAYER: PRODUCT PORTFOLIO
TABLE 66.BOEKEL SCIENTIFIC: COMPANY SNAPSHOT
TABLE 67.BOEKEL SCIENTIFIC: OPERATING SEGMENTS
TABLE 68.ELI LILLY: PRODUCT PORTFOLIO
TABLE 69.BIOLIFE SOLUTIONS: COMPANY SNAPSHOT
TABLE 70.BIOLIFE SOLUTIONS: OPERATING SEGMENTS
TABLE 71.BIOLIFE SOLUTIONS: PRODUCT PORTFOLIO
TABLE 72.CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 73.CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 74.CARDINAL HEALTH: PRODUCT PORTFOLIO
TABLE 75.GE: COMPANY SNAPSHOT
TABLE 76.GE: OPERATING SEGMENTS
TABLE 77.GE: PRODUCT PORTFOLIO
TABLE 78.HELMER: COMPANY SNAPSHOT
TABLE 79.HELMER: OPERATING BUSINESS SEGMENTS
TABLE 80.HELMER: PRODUCT PORTFOLIO
TABLE 81.SARTORIUS: COMPANY SNAPSHOT
TABLE 82.SARTORIUS: OPERATING BUSINESS SEGMENTS
TABLE 83.SARTORIUS: PRODUCT PORTFOLIO
TABLE 84.SARSTEDT GROUP: COMPANY SNAPSHOT
TABLE 85.SARSTEDT GROUP: OPERATING SEGMENTS
TABLE 86.SARSTEDT GROUP: PRODUCT PORTFOLIO
TABLE 87.TERUMO: COMPANY SNAPSHOT
TABLE 88.TERUMO: OERATING SEGMENT
TABLE 89.TERUMO: PRODUCT PORTFOLIO
TABLE 90.THERMO FISHER: COMPANY SNAPSHOT
TABLE 91.THERMO FISHER.: OPERATING SEGMENTS
TABLE 92.THERMO FISHER.: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.GLOBAL MEDICAL THAWING SYSTEM MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.LOW BARGAINING POWER OF SUPPLIERS
FIGURE 04.HIGH BARGAINING POWER OF BUYERS
FIGURE 05.HIGH THREAT OF SUBSTITUTES
FIGURE 06.MODERATE THREAT OF NEW ENTRANTS
FIGURE 07.MODERATE INTENSITY OF RIVALRY
FIGURE 08.TOP PLAYER POSITIONING, 2019
FIGURE 09.IMPACT ANALYSIS
FIGURE 10.COMPARATIVE ANALYSIS OF BLOOD MEDICAL THAWING SYSTEM MARKET, BY COUNTRY, 2019 & 2027 (%)
FIGURE 11.COMPARATIVE ANALYSIS OF EMBRYO MEDICAL THAWING SYSTEM, BY COUNTRY, 2019 & 2027 (%)
FIGURE 12.COMPARATIVE ANALYSIS OF OVUM MEDICAL THAWING SYSTEM, BY COUNTRY, 2019 & 2027 (%)
FIGURE 13.COMPARATIVE ANALYSIS OF SEMEN MEDICAL THAWING SYSTEM, BY COUNTRY, 2019 & 2027 (%)
FIGURE 14.COMPARATIVE COUNTRY ANALYSIS OF BLOOD BANK MEDICAL THAWING SYSTEM, 2019 & 2027 (%)
FIGURE 15.COMPARATIVE COUNTRY ANALYSIS OF HOSPITAL MEDICAL THAWING SYSTEM, 2019 & 2027 (%)
FIGURE 16.COMPARATIVE COUNTRY ANALYSIS OF TISSUE BANK MEDICAL THAWING SYSTEM, 2019 & 2027 (%)
FIGURE 17.COMPARATIVE COUNTRY ANALYSIS OF PHAMACEUTICAL AND BIOTECH COMPANIES MEDICAL THAWING SYSTEM, 2019 & 2027 (%)
FIGURE 18.COMPARATIVE COUNTRY ANALYSIS OF OTHERS MEDICAL THAWING SYSTEM, 2019 & 2027 (%)
FIGURE 19.BIOLIFE SOLUTIONS: NET SALES, 2017–2019 ($MILLION)
FIGURE 20.BIOLIFE SOLUTIONS: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 21.BIOLIFE SOLUTIONS: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 22.CARDINAL HEALTH: NET SALES, 2018–2020 ($MILLION)
FIGURE 23.CARDINAL HEALTH: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 24.CARDINAL HEALTH: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 25.GE: NET SALES, 2017–2019 ($MILLION)
FIGURE 26.GE: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 27.GE: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 28.MYLAN: NET SALES, 2017–2019 ($MILLION)
FIGURE 29.MYLAN: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 30.SARTORIUS: NET SALES, 2018–2020 ($MILLION)
FIGURE 31.SARTORIUS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 32.SARTORIUS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 33.TERUMO: NET SALES, 2017–2019 ($MILLION)
FIGURE 34.TERUMO: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 35.TERUMO: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 36.THERMO FISHER: NET SALES, 2017–2019 ($MILLION)
FIGURE 37.THERMO FISHER: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 38.THERMO FISHER: REVENUE SHARE, BY REGION, 2019 (%)
